|
Originally published In Press as doi:10.1074/jbc.M004453200 on July 7, 2000
J. Biol. Chem., Vol. 275, Issue 42, 32931-32939, October 20, 2000
Mitochondrial F0F1 ATP Synthase
SUBUNIT REGIONS ON THE F1 MOTOR SHIELDED BY
F0, FUNCTIONAL SIGNIFICANCE, AND EVIDENCE FOR AN
INVOLVEMENT OF THE UNIQUE F0 SUBUNIT F6*
Young Hee
Ko,
Joanne
Hullihen,
Sangjin
Hong, and
Peter L.
Pedersen
From the Department of Biological Chemistry, Johns Hopkins
University School of Medicine, Baltimore, Maryland 21205-2185
Received for publication, May 23, 2000, and in revised form, June 28, 2000
 |
ABSTRACT |
Studies reported here were undertaken to gain
greater molecular insight into the complex structure of mitochondrial
ATP synthase (F0F1) and its relationship
to the enzyme's function and motor-related properties. Significantly,
these studies, which employed N-terminal sequence, mass spectral,
proteolytic, immunological, and functional analyses, led to the
following novel findings. First, at the top of F1 within
F0F1, all six N-terminal regions derived from
+ subunits are shielded, indicating that one or more
F0 subunits forms a "cap." Second, at the bottom of
F1 within F0F1, the N-terminal region of the single subunit and the C-terminal regions of all three subunits are shielded also by F0. Third, and in
contrast, part of the subunit located at the bottom of
F1 is already shielded in F1, indicating that
there is a preferential propensity for interaction with other
F1 subunits, most likely and . Fourth, and
consistent with the first two conclusions above that specific regions
at the top and bottom of F1 are shielded by F0,
further proteolytic shaving of and subunits at these locations
eliminates the capacity of F1 to couple a proton gradient
to ATP synthesis. Finally, evidence was obtained that the
F0 subunit called "F6," unique to animal
ATP synthases, is involved in shielding F1. The significance of the studies reported here, in relation to current views
about ATP synthase structure and function in animal mitochondria, is discussed.
 |
INTRODUCTION |
ATP synthases represent one of natures' most unique enzyme
classes (reviewed in Refs. 1-3). Structurally, these enzymes are observed by electron microscopy (4-12) to consists of four distinct features, a headpiece, a basepiece, a central stalk or "stem
region" connecting the headpiece and basepiece, and a "second
stalk" extending from the basepiece to the top of the headpiece
(4-10). Animal ATP synthases contain, in addition, what appears to be
a fifth structural feature, a ring-like disc or "collar"
surrounding the central stalk (11). Biochemically, however, ATP
synthases separate most readily into only two units. One is a
water-soluble component, F1, containing five subunit types
in the ratio 3 3  , whereas the
other is a detergent-soluble component, F0, containing
three subunit types (a, b, c) in bacteria and at least 10 more in
animal systems (1-3). A regulatory protein, IF1, is found
also in isolated mitochondrial ATP synthases. A variety of studies
involving biochemica1 (13-25), electron microscopic (4-12), and x-ray
crystallographic (26-30) approaches, have shown that the headpiece and
central stalk are derived primarily from F1 subunits and
the basepiece and second stalk are derived primarily from
F0 subunits. In contrast, the subunit source of the
ring-like disc or "collar" surrounding the central stalk in animal
ATP synthases (11) remains unknown.
Nature's rationale for providing ATP synthases with this unique
molecular architecture has become apparent only in recent studies where
evidence that these fascinating enzymes contain two motors has been
mounting (31-33). One of the proposed motors is F1, which
is driven by ATP binding and/or hydrolysis (31), whereas the other is
contained within F0 and driven by a proton gradient (33).
During ATP synthesis, the proposed motor within F0,
composed of 10-12 subunit c molecules (30, 34) and a single subunit a,
is believed to drive the F1 motor in reverse (35) via a
central rotor, the F1- subunit. This subunit extends
from a ring of subunit c molecules in the F0 basepiece
(19), through the central stalk region, and finally through the center
of F1 where it interacts differently with each of the three
 pairs (26-29). During one 360° rotation of the subunit,
the binding of ADP and inorganic phosphate, the synthesis of ATP, and
the release of this ATP are believed to occur on each  pair as
proposed by the "binding change mechanism" (2, 36). During this
process, the subunit in bacteria, or its subunit equivalent in
animals, is also believed to rotate (32), presumably at the bottom of F1 within the central stalk region.
Although much has been learned about the structure and function of ATP
synthases as summarized above, a three-dimensional structure has not
been obtained for the complete enzyme (F0F1) from any source. In fact, of the 16 different subunit types within the
mitochondrial ATP synthase of animal cells, only two and a half of
these ( , , and about half of ) have been solved at atomic resolution (26, 28). Consequently, there are still many
important questions that remain unanswered about structure/function relationships in ATP synthases, and how, within these remarkably complex machines, energy coupling between the proposed proton gradient-driven motor within F0 is coupled to the reversal
of the ATP-driven F1 motor. Specifically, one important
question relates to the identity of exterior subunit regions at the top and bottom of F1 that are shielded by F0 in the
complete ATP synthase, because these regions may include
F0/F1 contact sites essential for energy
coupling during ATP synthesis. Although information about these
regions, particularly at or near the top of F1, is gradually being generated for the Escherichia coli and
chloroplast enzymes (12, 23), little information is available for
animal ATP synthases.
In studies reported below, we used a variety of approaches to identify
exterior subunit regions at the top and bottom of rat liver
F1 that are shielded by F0. We then assessed
the requirement of these regions for coupling a proton gradient to ATP
synthesis. In addition, we obtained evidence for the involvement of an
F0 subunit unique to animal ATP synthases.
 |
EXPERIMENTAL PROCEDURES |
Materials
Rats (Harlan Sprague-DawleyCD, white males)
were obtained from Charles River Breeding Laboratories. ATP,
MgCl2, 2EDTA,
DTT,1 tricine, Sephadex
G-25 (coarse), soybean trypsin inhibitor, oligomycin, and DCCD
were from Sigma. SDS, acrylamide, and bisacrylamide were from Bio-Rad,
PVDF membranes from Millipore, and Western blot reagents from Amersham
Pharmacia Biotech. Modified trypsin (sequencing grade), pyroglutamate
aminopeptidase, hexokinase, and glucose-6-phosphate dehydrogenase were
from Roche Molecular Biochemicals. The detergent CHAPS was
obtained from Anatrace, whereas sucrose, urea, and potassium phosphate
were from J.T. Baker. Coomassie Blue dye binding reagent for protein
determination was from Pierce, AEBSF was from Calbiochem, and
3,5-dimethoxy-4-hydroxy-cinnamic acid and -cyano-4-hydroxy-cinnamic acid were from Aldrich. Centriprep filtration units for protein concentration were from Amicon. Venturicidin was from BDH Chemicals. The antibodies to F0 components were generous gifts from
Drs. Y. Hatefi and Akemi Matsuno Yagi. All other products were of the highest purity or grade commercially available.
Methods
Purification of Mitochondrial ATP Synthase
(F0F1)--
This complex was purified from rat
liver mitochondria by a modification of a previously described method
developed in this laboratory (6). A washed submitochondrial particle
fraction, referred to previously as 3X membranes (6), was stored at
~15 mg/ml and 20 °C in TA buffer (50 mM Tricine, 1 mM ATP, 25 mM EDTA, 0.5 mM DTT, and
5% ethylene glycol, pH 7.9), thawed, and solubilized at 4 mg/ml in
0.6% CHAPS for l h on ice with occasional stirring. After
centrifugation for 1 h at 48,000 rpm at 4 °C in a 70.1-Ti rotor
in a Beckman Optima LE 80K ultracentrifuge to remove unsolubilized
material, the supernatant was concentrated using Amicon's Centriprep
filtration unit (molecular mass cutoff = 50 kDa). The
concentrate was diluted with TA buffer to give a CHAPS concentration of
0.1% and frozen in dry ice and ethanol, and then stored at 20 °C
for 3 h. The sample (~20 ml) was then thawed, and 5-ml aliquots
(2.0-2.5 mg/ml) were placed on 20 ml of 25% sucrose in TA buffer
without CHAPS and centrifuged 12 h and 45 min at 4 °C in the
same centrifuge described above but using the SW-28 rotor. The pellet,
F0F1 (7-10 mg/ml), judged to be >90% pure,
was stored at 80 °C in TA buffer. The specific activity was 14-15
µmol of ATP hydrolyzed × min 1 × mg 1 protein based on the ATPase and protein assays
described below.
Purification of the F1 Moiety of Mitochondrial ATP
Synthase--
F1 with a specific activity of about 25 µmol × min 1 × mg 1 in TrisCl buffer
was purified from isolated rat liver mitochondria exactly as described
by Catterall and Pedersen (37) with one modification. The terminal
Sephadex G-200 step was replaced by chromatography on a 2.1- × 13-cm
Sephadex G-25 column packed on top of a 1.5-cm layer of sea sand and a
1-cm layer of glass wool. It was then stored or prepared for use as
described by Ko et al. (38).
Preparation of Inner Mitochondrial Membrane Vesicles and
F1-depleted Vesicles, and Reconstitution of F1
with the F1-depleted Vesicles--
All steps were carried
out exactly as described previously by Pedersen and Hullihen (39).
Treatment of F0F1 with Pyroglutamate
Aminopeptidase--
To remove the N-terminally blocked group on the
subunit, F0F1 (1 mg/ml) was placed in a 200 µl of digestion buffer containing 100 mM sodium
Pi, pH 8.0, 10 mM EDTA, 5 mM DTT,
5% glycerol, 0.6% CHAPS, and pyroglutamate aminopeptidase (0.019 mg/ml). The enzyme was then incubated in this mixture first for 12 h at 4 °C and then for 2 h at 25 °C, after which the entire
reaction mixture was added to SDS sample buffer and analyzed by
SDS-PAGE. The subunit band was then subjected to N-terminal
sequence analysis exactly as described below.
Treatment of F1 and F0F1 with
Trypsin--
F1 and F0F1 (each 160 µg) were subjected to digestion for various incubation times at
25 °C in a final volume of 0.1 ml containing 250 mM
potassium Pi, pH 7.5, 5 mM EDTA, and 10 µg of
trypsin. Trypsin inhibitor (50 µg), or AEBSF at a final concentration
of 5 mM, was then added at various incubation times to stop
the reaction. Following the addition of ammonium sulfate to the mixture
to give 65% saturation, the resultant suspension was centrifuged at
13, 000 rpm in a Sorvall SS 34 rotor for 1 h at 25 °C.
Assay for ATPase Activity--
ATPase activity was assayed
exactly as described previously (37) by a spectrophotometric procedure
in which ADP formed was coupled to the pyruvate kinase and lactic
dehydrogenase reactions.
Assay for ATP Synthesis--
ATP synthesis was monitored
spectrophotometrically at 340 nm and 25 °C by coupling the
production of ATP to the reduction of NADP+ via the
hexokinase and glucose-6-phosphate dehydrogenase reactions. The assay
mixture contained, in a final volume of 1 ml, 10 mM potassium Pi, 10 mM succinate, 50 mM Tris acetate, 1 mM glucose, 1 mM
NADP+, 2.0 mM MgCl2, 2 mg/ml bovine
albumin, 200 mM sucrose, 20 IU hexokinase, 0.25 IU
glucose-6-phosphate dehydrogenase, and 100-200 µg of inner
mitochondrial membrane vesicles. The reaction was started by the
addition of 1 mM ADP.
SDS-PAGE--
This was carried out as indicated either by the
method of Laemmli (40) or the more sensitive method of Schägger
and von Jagow (41) for separating proteins in the molecular mass range of from 1 to 100 kDa.
Western Analysis--
After conducting SDS-PAGE, the proteins on
the gel were transferred electrophoretically at 4 °C in 10 mM CAPS, 10% methanol transfer buffer, pH 11, onto a PVDF
membrane (1 h at 100 V and 0.2 amp). The membrane was then blocked for
l h with 2% bovine albumin plus 5% non-fat dry milk in
phosphate-buffered saline T buffer (80 mM
Na2HPO4, 20 mM
NaH2PO4, 100 mM NaCl, 0.1% Tween 20, pH 7.5), incubated for 1 h at 23 °C with polyclonal
antibodies as indicated in the figure legends, and then further
incubated for 1 h at 23 °C with secondary antibody (horseradish
peroxidase-conjugated anti-rabbit IgG). The immunoreactive bands were
detected by an enhanced chemiluminescence (ECL) system.
Mass Spectral Analysis--
Mass spectra were acquired on
samples of 10-20 pmol in a PerSeptive Biosystems Voyager MALDI-TOF-DE
mass spectrometer using a nitrogen laser (wavelength 337 nm). The
matrix was either 3,5-dimethoxy-4-hydroxy-cinnamic acid or
-cyano-4-hydroxy-cinnamic acid. Positive ion mass spectra were
analyzed using PerSeptive GRAMS software version 3.01c.
N-terminal Sequence Analysis--
F1 or
F0 subunits were transferred from SDS-PAGE gels onto PVDF
membranes by electroblotting. Transfer conditions were for 1 h in
10 mM CAPS buffer, 10% methanol, pH 11, at 4 °C. The
peptides were then excised and subjected to N-terminal sequencing (42) using an Applied Biosystems 475A protein sequencing system (43).
Determination of Protein--
Three different methods were used
to determine protein, Lowry et al. (44), biuret (45), and
Coomassie dye (Pierce). In all cases bovine albumin was used as the standard.
 |
RESULTS |
Objectives and Systems Employed--
The first objective of this
study was to identify exterior regions on F1 that are
shielded by F0 within a fully active, complete ATP synthase
(F0F1) preparation from an animal mitochondrial
source. The regions on F1 of most interest (Fig.
1A) were its top where the
N-terminal regions of and subunits reside (26-28) and its bottom where the C-terminal regions of these same subunits (26-28) reside together with part of the subunit (26, 28), the subunit
(25, 30), and likely also the subunit. The second objective was to
assess the importance of these regions for coupling an electrochemical
proton gradient to ATP synthesis. This information is generally lacking
for animal ATP synthases, which are much more complex in their
F0 subunit composition than related enzymes from E. coli and chloroplasts. The third objective was to identify at
least one F0 subunit unique to the animal enzyme involved
in shielding F1, because such a subunit would represent a
candidate for part of the stator or second stalk believed to stabilize
the F1 motor. To complete these objectives, it was
essential to have at hand, in addition to our extensively studied rat
liver F1 preparation (25, 28, 37-39), an intact, highly
purified preparation of the complete ATP synthase from the same source.
This was accomplished by introducing several modifications (see
"Methods") into the CHAPS-based procedure previously developed in
this laboratory (6). The resultant preparation exhibits a specific
activity of 14-15 µmol of ATP hydrolyzed × min 1 × mg 1 protein, contains all 16 subunits (Fig.
1B) previously reported for the bovine heart ATP synthase
(20), and is markedly inhibited by oligomycin, DCCD, and venturicidin
(Fig. 1C), agents known to bind to F0 (46,
47).

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 1.
A, structure of rat liver F1
at 2.8 Å (28) depicting those regions examined in this study for
possible shielding by subunits of F0. The ribbon
representation of the F1 structure was constructed using
the atomic coordinates of the rat liver enzyme (1mab (28)) using the
program Quanta. The -helical, -sheet, and loop structures are
colored in green, yellow, and purple,
respectively. Nucleotides are shown in red. Regions examined
in this study are located at the top and bottom of F1.
These include the N-terminal regions of the and subunits
(top) and the C-terminal regions of these same subunits
(bottom), together with the central stalk ("stem")
region (bottom). The central stalk region includes two
sections, one that projects about 20 Å out of the F1
headpiece as revealed by x-ray crystallography (28) and shown in the
figure, and another section (not shown) that is not yet resolvable by
x-ray crystallography and is predicted to extend about another 30 Å (30). Regions of the subunit that were resolved by crystallography
include residues 4-48, 209-273, and 77-90 (28). The subunit (not
shown) is believed to be located also within the region of the central
stalk, both on the basis of biochemical studies (25) and on the basis
of the recent structure at 3.9-Å resolution of a yeast
F1-(subunit c)10 complex (30). B,
SDS-PAGE gels of F1 and F0F1
preparations used in this study. F1 and
F0F1 were purified and subjected to SDS-PAGE as
described under "Methods." The presence of all known
F0F1 subunits (16) was confirmed by N-terminal
sequence analyses ("Methods") and/or by Western analyses
("Methods") using specific antibodies. C, results of
ATPase assays demonstrating that the F0F1
preparation used in this study is inhibited by agents known to act at
the level of F0. ATPase assays were carried out in a 1-ml
system as indicated under "Methods." In all cases, 14 µg of
F0F1 was used to initiate the assay, and where
shown the following inhibitors were added: oligomycin (2.5 µg), DCCD
(5 µg), or venturicidin (5 µg).
|
|
Evidence That the N-terminal Regions of the and Subunits
Located at the Top of F1 Are Shielded by One or More
F0 Subunits in the Complete ATP Synthase--
Here,
studies focused on the N-terminal regions of the three and three
subunits as they are known from the atomic resolution structures of bovine heart and rat liver F1 (Fig.
1A) to project from the top of the enzyme (26, 28). To
determine whether one or more of the six N-terminal regions derived
from these subunits are shielded by F0, we compared the
extent to which F1, both alone and as part of the complete
ATP synthase complex (F0F1), is shaved by
endogenous proteases during purification. This necessitated carrying
out N-terminal sequence analysis on both the and subunits of
preparations of rat liver F1 and
F0F1 purified as described under "Methods."
Therefore, following purification, these subunits were transferred from
SDS-PAGE gels onto PVDF membranes by electroblotting, excised, and
subjected to sequence analyses, also as described under "Methods."
In these experiments, the N-terminal regions of subunits derived
from the F0F1 preparation could be sequenced
only following prior treatment with the enzyme pyroglutamate aminopeptidase (48), which removes from the blocked N termini pyrrolidone carboxylic acid (Fig.
2A, inset), a
cyclic form of glutamine.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 2.
A and B, N-terminal sequences
obtained for the and subunits within purified preparations of
F0F1. The sequence of the subunit was
obtained following removal of the cyclic glutamine residue
(A, inset) blocking the N terminus. Removal of
the cyclic glutamine residue, preparation of samples for N-terminal
sequence analyses, and the sequencing method used are described under
"Methods." C and D, N-terminal sequences
obtained for the and subunits within purified preparations of
F1. See "Methods" for procedural details. E,
summary of A-D. The summary diagram emphasizes that, when
F1 is isolated in the absence of F0, endogenous
proteases cleave 2 amino acids, Q and K from the N-terminal region of
subunits and a 6 amino acid peptide, AAQSSA, from the N-terminal
region of subunits.
|
|
The results of these experiments revealed that the N-terminal regions
of all and subunits remain intact in
F0F1 during its purification from mitochondria,
because the amino acid sequences obtained (Fig. 2, A and
B) correspond to those predicted for the mature sequences of
these subunits. In contrast, the same subunits are shaved during the
purification of F1 (Fig. 2, C and D).
Thus, two amino acids, Q and K, are shaved from subunits, whereas the 6-amino acid peptide, AAQSSA, is shaved from subunits (Fig. 2E). The degree of shaving remained the same in a number of
F1 preparations examined. In all cases the N-terminal
sequence data obtained was homogeneous, thus ruling out the possibility
of differences among the N-terminal regions of each of the three subunits and each of the three subunits. These results indicate
that, when within the complete ATP synthase, all six N-terminal regions
of + subunits located at the top of F1 are shielded
during purification from specific proteases endogenous to the
mitochondria. Moreover, they strongly implicate one or more
F0 subunits as comprising this shield, which appears to
"cap" the top of F1 rather than being confined to a
limited region. Consistent with these conclusions, in experiments not
reported here, treatment of purified F0F1 with trypsin for 1.5 h was unable to cleave the N-terminal regions of
either the F1 or subunits despite the presence of
potential cleavage sites (R and/or K) in both cases.
Evidence That, of the Three Remaining Subunits ( , , and ),
Only the N-terminal Region of , Located at the Bottom of
F1, Is Shielded by One or More F0 Subunits in
the Complete ATP Synthase--
A comparison of amino acid sequencing
data presented in Figs. 3A and
3B, and summarized in 3G, shows that the
N-terminal region of the subunit has not been shaved by proteases
during isolation of F1. Rather, its N-terminal sequence is
identical to that found in purified F0F1, and
to the known sequence for this subunit. This is an expected result,
which serves as a control. Thus, it is known from the atomic resolution
structures of bovine heart and rat liver F1 preparations
(26, 28) that the N-terminal region of the subunit is tucked deep
inside the central cavity of the F1 headpiece where it is
well shielded. In contrast, sequencing data for the subunit
presented in Figs. 3C and 3D, and summarized in
3G, show that in F1 purified alone a 4-amino
acid peptide, AQAA, is shaved from its N-terminal region. However, when
the subunit is purified as part of the complete
F0F1 complex, the AQAA peptide is retained.
Finally, a comparison of N-terminal sequencing data presented in Figs.
3E and 3F, and summarized also in Fig.
3G, show that the subunit, just as the subunit, has not been shaved during isolation, indicating that it may be shielded also within F1. To date, little is known about the precise
location and role of the subunit in mitochondrial ATP synthases,
although it has been reported to subfractionate with a  
complex (49) and to bind to the subunit (50).

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 3.
A and B, N-terminal sequences
obtained for the subunit within purified preparations of
F0F1 (A) and F1
(B). Preparation of samples for N-terminal sequence analyses
and the sequencing method used are described under "Methods."
C and D, N-terminal sequences obtained for the
subunit within purified preparations of
F0F1 (C) and F1
(D). Preparation of samples for N-terminal sequence analyses
and the sequencing method used are described under "Methods."
E and F, N-terminal sequences obtained for the
subunit within purified preparations of
F0F1 (E) and F1
(F). Preparations of samples for N-terminal sequence
analyses and the sequencing method used are described under
"Methods." G, summary of A-F. The summary
diagram emphasizes that the N-terminal regions of the and subunits are not altered by endogenous proteases during purification of
either F0F1 or F1, whereas the
4-amino acid peptide AQAA is cleaved from the N-terminal region of the
subunit in F1 but not
F0F1.
|
|
The studies described here, taken together with the above studies,
indicate that, within the complete liver mitochondrial ATP synthase,
regions of F0 located at both the top and bottom of
F1 shield the N-terminal regions of three of its subunit
types ( , , and ), whereas the remaining two subunit types ( and ) are shielded or tightly folded within F1.
Limited Treatment of Isolated F1 with Trypsin Results
in Further Shaving of Its and Subunits While Leaving the
Smaller Subunits , , and Unaltered--
Results presented in
Fig. 4 (A and B)
show that treatment of isolated F1 with trypsin for as long
as 90 min has no effect on the staining intensities or mobilities of
the , , and subunits of F1 in SDS-PAGE gels but
does noticeably affect the mobility of the subunit. Two different
gel systems were used in these experiments. One contained 7.5%
acrylamide (Fig. 4A), which separates best the , , and
subunits but not the and subunits, which migrate with the
dye front. The second contained 15% acrylamide (Fig. 4B),
which separates the , , and subunits better than the and
subunits.

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 4.
A and B, SDS-PAGE pattern of
F1 following limited treatment with trypsin. F1
was previously treated with trypsin exactly as described under
"Methods" for the times indicated at the top of the gel and then
subjected to SDS-PAGE in gels containing 7.5% (A) or 15%
(B) polyacrylamide. The 7.5% gels resolved best the ,
, and subunits of F1 but not the smaller subunits
and , which migrated with the dye front. In contrast the 15%
gels resolved the subunits , , and better than the and
subunits. C and D, N-terminal sequences
obtained for the subunits (C) and the subunits
(D) following treatment of F1 with trypsin for l
h. The summary diagram at the bottom of C shows that
trypsin shaves 13 amino acids more off the N-terminal region of the subunit than the 2 amino acids (Q and K) shaved off by endogenous
proteases during purification (Fig. 2E). The summary diagram
at the bottom of D shows that trypsin shaves only 3 amino
acids more off the N-terminal region of the subunit than the 6 (AAQSSA) shaved off by endogenous proteases during purification (Fig.
2E).
|
|
When all five F1 subunits from the SDS-PAGE gels were
subjected to N-terminal sequence analyses, it was found that a 13-amino acid peptide (TGTAEMSSILEER) had been cleaved from the N-terminal region of the subunit (Fig. 4C) and a 3-amino acid
peptide (APK) from the N-terminal region of the subunit (Fig.
4D). In data not presented here, the N-terminal regions of
the , , and subunits were found to be unaltered. Because the
decrease in mass of the subunit appeared by inspection of SDS-PAGE
gels (Fig. 4, A and B) to be greater than the
mass of the 13-amino acid peptide cleaved from its N terminus, this
suggested that trypsin may have cleaved also at the C terminus. For
this reason we subjected both isolated F1 and
trypsin-treated F1 to MALDI-TOF-DE mass spectral analysis
as described under "Methods." Consistent with SDS-PAGE and
N-terminal sequence analyses, these studies confirmed that the mass of
the , , and subunits were unaltered and showed that the mass
of each subunit had decreased by only 341 Da (Fig. 5A), as expected from the loss
of the APK peptide. In contrast, however, the mass of each subunit
decreased by 4425 Da, of which only 1406 Da could be accounted for by
the 13-amino acid peptide cleaved from the N-terminal region (Fig.
4C). Significantly, the remaining decrease in mass, which
must come from the C-terminal region, corresponds most closely to a
26-amino acid -helix resulting from trypsin cleavage between amino
acid Arg-484 and Ser-485 (Fig. 5B).

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 5.
A, summary of molecular masses obtained
for F1 subunits before and after limited treatment with
trypsin. F1 was subjected to limited treatment with trypsin
for 1 h exactly as described under "Methods" and then analyzed
in a MALDI-TOF-DE mass spectrometer, also as described under
"Methods." The masses obtained from two different experiments
varied less than 1%. B, predicted trypsin cleavage site
within the C-terminal region of the subunit. Taking into
consideration the large total mass loss of the subunit, and the
known loss of mass from its N-terminal region, the mass loss arising
from its C-terminal region was calculated and found to correspond
precisely to loss of the 26-amino acid peptide shown (see text for
discussion). C, lack of effect of trypsin on the mobility of
the and subunits within purified F0F1.
F0F1 was treated for up to 1.5 h with trypsin
as described under "Methods" and then subjected to SDS-PAGE, also
as described under "Methods."
|
|
These results, while demonstrating that limited trypsin treatment of
isolated F1 causes further shaving of the exterior
N-terminal regions of both the and subunits located at the top
of the molecule, and the exterior C-terminal helix of the subunit
located at its bottom, also show that all three of the smaller subunits ( , , and ) are resistant to limited trypsin treatment.
Significantly, in other studies it was shown that trypsin treatment of
the complete ATP synthase (F0F1), in contrast
to treatment of F1, had no detectable effect on the
electrophoretic mobility of subunits in SDS-PAGE (Fig.
5C), indicating that F0 shields the C-terminal
regions of all three of these subunits near the bottom of the
F1 headpiece.
Trypsin-treated F1, Although Active as an ATPase and
Capable of Rebinding to F0 within F1-depleted
Inner Mitochondrial Membranes, Is Incapable of Coupling a Proton
Gradient to ATP Synthesis--
Results presented in Fig.
6A show that those conditions
under which trypsin further shaves the N-terminal regions of both and subunits at the top of rat liver F1, and the
C-terminal region of the subunits at its bottom (Figs. 4 and 5),
are without effect on the capacity of the enzyme to catalyze ATP
hydrolysis. Moreover, similar to isolated F1,
trypsin-treated F1 is able to restore to
F1-depleted inner membrane vesicles (IMVs) the capacity to
catalyze high rates of ATP hydrolysis inhibited by oligomycin (Fig.
6B, left) and DCCD (not shown). This shows that
trypsin-treated F1 is capable of binding appropriately to
the basepiece of F0 where the sites of action of oligomycin
(subunits c and a) and DCCD (subunit c) are located (46, 47). However,
unlike isolated F1, which is able to restore the capacity
of F1-depleted, actively respiring IMVs to catalyze ATP
synthesis inhibited by oligomycin, DCCD (not shown), and the
protonophore 2,4-dinitrophenol, trypsin-treated F1 is not
effective in this capacity (Fig. 6B, right).
(IMVs of rat liver mitochondria, prior to treatment with urea to
deplete F1 and provide F1-depleted IMV, exhibit
specific activities for ATP hydrolysis in the range of 2000-3000 nmol
of ATP hydrolyzed × min 1 × mg 1
protein and specific activities for ATP synthesis in the range of
100-250 nmol × min 1 × mg 1
protein.)

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 6.
A, effect of trypsin on the ATPase
activity of rat liver F1 as a function of time.
F1 was treated with trypsin exactly as described under
"Methods" for the times indicated and then assayed for ATPase
activity by the spectrophotometric method, also described under
"Methods." B, assessment of the capacity of
trypsin-treated F1 to bind to F1-depleted inner
mitochondrial membrane vesicles and restore ATPase and ATP synthetic
activities. Preparation of F1-depleted inner membrane
vesicles by treating inner membrane vesicles with 3.2 M
urea, and reconstitution of F1 (300 µg) or
trypsin-treated F1 (300 µg) with the depleted vesicles
(0.5 mg), was carried out exactly as described previously (39). ATPase
and ATP synthetic activities were assayed as described under
"Methods." Where indicated, oligomycin (2.5 µg/ml), DCCD (5 µg/ml), or 2,4-dinitrophenol (100 µM) was added.
Standard deviations are based on three different experiments. (In
experiments not presented here, DCCD (5 µg/ml) inhibited by >90%
the rates of ATP hydrolysis and ATP synthesis in all cases.)
|
|
These results indicate that one or more of the exterior,
trypsin-accessible regions on F1 defined above are critical
for coupling a proton gradient to ATP synthesis in the inner
mitochondrial membrane, although they are of little or no importance to
the enzyme for catalyzing ATP hydrolysis or for binding to
F0.
Evidence for an Involvement of the Unique F0 Subunit
Called F6 in Shielding F1--
Having acquired
information that regions on rat liver F1, at its top and
bottom, are shielded by F0, and that one or both of these
locations on F1 may be necessary for coupling a proton gradient to ATP synthesis, our attention turned to the
involvement of F0. Here the major goal was to identify one
or more F0 subunits unique to the animal system involved in
shielding F1 within the complete
F0F1 ATP synthase. The F0 subunits
named "F6," "OSCP," and "d" were considered to
be likely candidates, because these subunits are not integral membrane
proteins (18, 51, 52). The strategy employed took advantage of our
knowledge that the N-terminal regions of each subunit shielded by
F0 at the top of F1 has its N terminus blocked
by pyrrolidone carboxylic acid. Therefore, it was rationalized that, by
monitoring the ability of a deblocking enzyme to gain entrance to the N
terminus of the blocked subunit in F0Fl
after the addition of a mild dissociating agent, while monitoring the
release of any F0 subunits, we might be able to identify
one or more F0 subunits involved in shielding F1.
Based on the above strategy and considerable preliminary work, it was
found that the deblocking enzyme (pyroglutamate aminopeptidase) gains
access to the N terminus of the subunit after treatment of
F0F1 with 0.6% CHAPS for 14 h (12 h at
4 °C and then 2 h at 25 °C). Thus, the N-terminal region of
the subunit following SDS-PAGE and electroblotting onto a PVDF
membrane could now be sequenced (Fig.
7A), verifying that deblocking
had occurred. Significantly, 1 M urea, when included under
the above conditions, actually stabilized F0F1
and prevented the deblocking enzyme from gaining access to the N
terminus of the subunit (Fig. 7B). When both the
supernatant and pellet following treatment of
F0F1 with CHAPS, but without urea, was analyzed
by immunoblotting with an antibody specific for F6, all of
this subunit was recovered in the supernatant (Fig. 7C,
Condition 1). In contrast, when 1 M urea was
present, F6 was not detected in the supernatant (Fig.
7C, Condition 2) but remained with the pellet.
Experiments conducted in an identical manner but using antibodies
specific for OSCP, showed that this subunit is also released into the
supernatant (Fig. 7D, Condition 1). However, in
this case 1 M urea fails to prevent its release (Fig. 7D, Condition 2). These results indicate that
F6, but not OSCP, plays a primary role in making the top of
F1 inaccessible to the subunit-deblocking enzyme.
Results obtained with an antibody to subunit d not presented here,
although less clear, mimicked most closely those obtained with
F6, indicating that subunit d may also shield in part the
top of F1.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 7.
A, N-terminal sequence of the
F1 subunit obtained after prior treatment of
F0F1 with the detergent CHAPS and then with the
deblocking enzyme pyroglutamate amino peptidase.
F0F1 (200 µg) was incubated for 12 h at
4 °C and then for 2 h at 25 °C in a 0.2-ml system containing
100 mM sodium Pi, pH 8.0, 10 mM
EDTA, 5 mM DTT, 5% glycerol, and 0.6% CHAPS. Following
SDS-PAGE, the subunit band was subjected to N-terminal sequence
analysis exactly as described under "Methods." B,
absence of N-terminal sequence data for the subunit upon treating
F0F1 as in A but in the presence of
urea. All conditions were exactly as in A with the exception
that 1 M urea was present. In control studies, urea was
shown to be without effect on the activity of the deblocking enzyme.
C, Western blots obtained with an antibody to the
F0 subunit "F6" following SDS-PAGE of
detergent extracts of F0F1 treated as in
A or as in B. F0F1
samples were treated exactly as in A with or without urea
and then centrifuged at 14,000 rpm for 15 min in a microcentrifuge at
25 °C. The supernatant was removed and boiled for 20 min and then
centrifuged at 14,000 rpm for 30 min at 25 °C. The final supernatant
was then removed and subjected to SDS-PAGE/Western blot analysis
exactly as described under "Methods" using a polyclonal antibody to
F6. D, experiments were carried out exactly as
described in C using a polyclonal antibody to OSCP rather
than F6.
|
|
 |
DISCUSSION |
The novel set of studies reported here were undertaken to gain
greater insight into the predicted motor-related features of ATP
synthases from animal cells. The objectives were 3-fold and focused on
(a) identifying exterior regions at the top and bottom of
the F1 motor that are shielded by F0;
(b) determining the importance of these regions for coupling
an electrochemical proton gradient via the motor in F0 to
the synthesis of ATP on F1; and (c) identifying one or more F0 subunits unique to animal ATP synthases
involved in shielding F1. Each of these objectives was
achieved either fully or in part.
Clearly, as revealed by N-terminal sequence analyses (Figs. 1 and 2),
exterior regions at both the top and bottom of rat liver F1
within the complete ATP synthase are shielded from limited proteolysis
arising from endogenous proteases during purification. Shielded regions
include the N-terminal regions of all and subunits, which are
known from the atomic resolution structure of rat liver F1
to reside at its top (28), and the N-terminal region of the single subunit, which is inferred from biochemical studies to reside at its
bottom (25). Treatment of the complete ATP synthase
(F0F1) with trypsin is also without effect on
the N-terminal regions of these same subunits, providing additional support that they are shielded by F0. These finding,
although identifying potential F0/F1 contact
regions in the complete rat liver ATP synthase, also implicate
F1 as being "capped" at its top by one or more subunits
derived from F0 and shielded at its bottom.
Significantly, the exterior N-terminal regions of F1, which
are shielded from limited proteolysis during isolation of
F0F1, i.e. the QK dipeptide of the
subunit (Fig. 2E), the AAQSSA hexapeptide of the subunit (Fig. 2E), and the AQAA tetrapeptide of the subunit (Fig. 3G), are not required for F1 to
restore ATP synthesis to F1-depleted inner membrane
vesicles (Fig. 6B). However, if the endogenously shaved
F1 preparation is shaved further at both its top and bottom
by exogenously added trypsin, the enzyme is unable to catalyze ATP
synthesis when reconstituted with F1-depleted inner
membrane vesicles (Fig. 6B). This loss of physiological function occurs despite the fact that the more closely shaved F1 fully retains both its catalytic ATPase activity (Fig.
6A) and its capacity to bind in a normal manner to
F1-depleted inner membrane vesicles (Fig. 6B).
Specifically, trypsin removes from the subunit's N-terminal region
an additional 13 amino acids, TGTAEMSSILEER (Fig. 4C), and
from its C-terminal region a 26-amino acid -helix,
SDGKISEQSDAKLKEIVTNFLAGFEP (Fig. 5B), while removing also
the tripeptide APK from the N-terminal region of the subunit (Fig.
4D). Taken together, these findings summarized in Fig.
8A indicate that one or more
of these trypsin-cleaved exterior regions, which are also shielded by
F0 when within the complete ATP synthase (Figs. 2, 3, and
5), are critical for the capacity of F1 to couple an
electrochemical proton gradient to the synthesis of ATP.

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 8.
A, summary of exterior regions of
F1 subunits shielded by F0 that are
nonessential for mitochondrial ATP synthesis, and those of which one or
more is essential. Blue italicized letters
designate those exterior amino acid residues that are not essential,
while red letters inside dotted boxes designate those of
which one or more is essential. B, model of rat liver
mitochondrial ATP synthase incorporating conclusions derived from the
novel findings reported here. Experimental data reported
here are consistent with a model for animal ATP synthases in which
(a) one or more F0 subunits completely shields
the top of F1 forming a cap; (b) one or more
F0 subunits also shields the bottom of the F1
headpiece, perhaps forming a collar; and (c) components of
F1, most likely and , shield the subunit within
the region of the central stalk at the bottom of F1. The
data reported are consistent also with a role for the unique
F0 subunit F6 in helping shield F1,
most likely at its top, although another location cannot be completely
ruled out.
|
|
Additional results presented here provide new information about the
relationship of F0 in the complete ATP synthase to the central stalk region of F1, i.e. the region that
extends from the bottom of the F1 headpiece to the
basepiece of F0, a distance of about 50 Å (30). From
SDS-PAGE, N-terminal sequencing, and mass spectral studies following
treatment with trypsin (Figs. 4 and 5), it is clear that subunit is
already well protected in the central stalk region within
F1. This shield is likely provided, at least in part, by
the subunit of F1, a view that is supported by previous
work in this laboratory on rat liver F1 (25) and from the
low resolution structure of yeast F1 in complex with a
decamer of the subunit c of F0 (30). The subunit of
F1, which binds to the subunit (50), may also comprise,
in part, the shield that protects the subunit within
F1. Because studies reported here implicate F0
as shielding the N-terminal region of the subunit (Fig. 3,
C and D), it would appear that in the intact ATP
synthase complex, one or more components of F0 may reside
sufficiently near the central stalk region to form contacts, but that
these contacts may not be directly in contact with the subunit. In other words, the subunit in the central stalk region may be doubly shielded, with the first layer involving the and subunits of F1, and the second shield one or more subunits of F0.
Finally, studies reported here show that those conditions that make the
N-terminally blocked residue (Q*) of the subunit at the top of
F1 accessible in F0F1 to a
deblocking enzyme also result in the release of the F0
subunit called F6 (Fig. 7). Moreover, conditions that
prevent the N-terminally blocked residue from becoming accessible to
the deblocking enzyme also prevent the release of F6 (Fig.
7). These findings are consistent with a location, or partial location,
of F6 at the top of F1 in the complete ATP synthase complex of rat liver, although they do not exclude its interaction or partial interaction at other locations. Significantly, F6, a small 8.93-kDa protein, required for ATP synthesis in
inner mitochondrial membrane vesicles (52), is not found among the F0 subunits in the simpler ATP synthase preparations
derived from E. coli and chloroplasts (1-3). Therefore, the
novel finding reported here about F6 is of special
interest, and in future studies may help reveal why the F0
unit of animal ATP synthases are much more complex than the
F0 units of the E. coli and chloroplast enzymes.
When conclusions from all the studies described here are considered, we
envision an overall structural model for the rat liver ATP synthase in
which one or more components of F0 extend from its
basepiece to the top of the headpiece of F1 (Fig.
8B). At the bottom of F1, components of
F0 are considered to associate closely or "hug" the
central stalk region forming a "collar" that shields the C-terminal
regions of the three subunits. At the top of F1, the
extension of this "second stalk" is considered to cover completely
the N-terminal regions of all and subunits, thus providing a
"cap." In addition, the cap may be composed, at least in part, by
the F0 subunit F6, unique to animal ATP
synthases. This model, derived from using a variety of approaches and
methodologies, is consistent with current views about ATP synthase
structure, which envision the presence of a stator connecting two
motors, one within the F1 headpiece and another within the
F0 basepiece (31-33, 35). In addition, this model and the
experimental work on which it is based provide biochemical support for
the recent electron microscopic study of bovine heart ATP synthase,
showing a collar around the central stalk and a mass at the top of the F1 (11), and support for a similar study conducted on the
E. coli ATP synthase in which a mass was also observed on
the top of F1 (12). Taken together, these studies suggest
that earlier models (53-55) depicting the stator or second stalk as
interacting with only one  pair and failing to extend from the
basepiece of F0 to the top of F1 may require revision.
Significantly, the extension of the stator to the top of F1
may have important functional consequences, because not one but all
three  pairs containing the catalytic sites must be stabilized during ATP synthesis. Moreover, that part of the stator that resides at
the top may be important also in facilitating formation of those
critical contacts recently suggested to be important in the assembly of
the -barrel domains (56).
 |
ACKNOWLEDGEMENTS |
We are grateful to Jodie Franklin for help in
obtaining N-terminal sequence and mass spectral data on F1,
and to Drs. Youssef Hatefi and Akemi Matsuno-Yagi for supplying
antibodies to F0 subunits.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant CA 10951 (to P. L. P.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The amino acid sequence of this protein can be accessed through
NCBI Protein Database under NCBI accession numbers: P15999 ( ),
P10719 ( ), P35435 ( ), P35434 ( ), and P29418 ( ).
To whom correspondence should be addressed: Dept. of Biological
Chemistry, Johns Hopkins University, School of Medicine, 725 North
Wolfe St., Baltimore, MD 21205-2185. Tel.: 410-955-3827; Fax:
410-614-1944; E-mail: ppederse@welchlink.welch.jhu.edu.
Published, JBC Papers in Press, July 7, 2000, DOI 10.1074/jbc.M004453200
 |
ABBREVIATIONS |
The abbreviations used are:
DTT, dithiothreitol;
DCCD, N, N'-dicyclohexylcarbodiimide;
CHAPS, [3-cholamidopropyl]dimethylammonio-1-propanesulfonate;
CAPS, 3-(cyclohexylamino)propanesulfonic acid;
TRICINE, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl] glycine;
PAGE, polyacrylamide gel electrophoresis;
PVDF, polyvinylidene difluoride;
MALDI-TOF MS, matrix-assisted laser desorption time of flight mass
spectrometry;
AEBSF, 4-(2-aminoethyl)benzenesulfonylfluoride
hydrochloride;
IMV, inner membrane vesicle(s);
OSCP, oligomycin
sensitivity conferring protein.
 |
REFERENCES |
| 1.
|
Weber, J.,
and Senior, A. E.
(1997)
Biochim. Biophys. Acta
1319,
19-58
|
| 2.
|
Boyer, P. D.
(1997)
Annu. Rev. Biochem.
66,
714-749
|
| 3.
|
Altendorf, K.,
Stalz, W.-D.,
Greie, J.-C.,
and Deckers-Hebestreit, G.
(2000)
J. Exp. Biol.
203,
19-28
|
| 4.
|
Kagawa, Y.
(1972)
Biochim. Biophys. Acta
265,
297-338
|
| 5.
|
Soper, J. W.,
Decker, G. L.,
and Pedersen, P. L.
(1979)
J. Biol. Chem.
254,
11170-11176
|
| 6.
|
McEnery, M. W.,
Buhle, E. L., Jr.,
Aebi, U.,
and Pedersen, P. L.
(1984)
J. Biol. Chem.
259,
4642-4651
|
| 7.
|
Gogel, E. P.,
Lucken, U.,
and Capaldi, R. A.
(1987)
FEBS Lett.
219,
274-278
|
| 8.
|
Wilkens, S.,
Dunn, S. D.,
and Capaldi, R. A.
(1994)
FEBS Lett.
354,
37-40
|
| 9.
|
Birkenhagen, R.,
Hoppert, M.,
Deckers-Hebestreit, G.,
Mayer, F.,
| |